Xiaoyan Zhou
Yunnan Normal University(CN)Shanghai Medical College of Fudan University(CN)Central South University(CN)Qingdao University of Science and Technology(CN)Ludong University(CN)Yunnan University(CN)Haikou City People's Hospital(CN)Yanan University Affiliated Hospital(CN)First People's Hospital of Yunnan Province(CN)Fudan University Shanghai Cancer Center(CN)Shanghai Cancer Institute(CN)Wuxi Fourth People's Hospital(CN)Second Affiliated Hospital of Xi'an Jiaotong University(CN)Qingdao University of Technology(CN)Hubei University of Technology(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Liver physiology and pathology
Most-Cited Works
- → PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients(2004)1,856 cited
- → Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis(2004)547 cited
- → Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers(2004)312 cited
- → ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells(2006)200 cited
- → 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival(2009)175 cited
- → Lineage Infidelity of MDA-MB-435 Cells(2004)162 cited